Ran Jing, Ph.D.

Dr. Ran Jing is a stem cell biologist and immunologist whose research focuses on human pluripotent stem cell–based models of hematopoiesis and immune cell development, with the goal of advancing cellular immunotherapies. He received his Ph.D. in Cell Biology and Regenerative Medicine from the Medical University of South Carolina. Following his Ph.D., Dr. Jing pursued postdoctoral training in the laboratory of Dr. George Daley at Harvard Medical School.

In 2026, Dr. Jing joined the University of California, Irvine School of Medicine as an Assistant Professor in the Department of Biological Chemistry and the Sue & Bill Gross Stem Cell Research Center. His research focuses on harnessing the potential of human pluripotent stem cells to generate lymphoid cells and to develop next-generation, off-the-shelf cellular immunotherapies for cancer and immune-related diseases.

The Jing laboratory studies how human stem cells can be guided to become functional immune cells for research and therapeutic applications. We use induced pluripotent stem cells (iPSCs) to generate diverse immune cell types and investigate the mechanisms underlying their development and function.

We engineer these cells to enhance their ability to recognize and respond to disease-related targets, including through chimeric antigen receptor (CAR) technology. By integrating stem cell biology and immunology, our work aims to establish reliable human immune cell models and advance innovative approaches for cellular immunotherapy and immune-based treatments.